Early reports of carotid stenting mainly used balloon-expandable stents such as the Palmaz stent (Johnson & Johnson Interventional Systems), which can usually be positioned with greater precision than ...

Individuals with diabetes mellitus have worse outcomes, and particularly a higher rate of restenosis, following revascularization than those without diabetes. The advent of drug-eluting stents has ...

Background and aim: Covered self-expandable metal stents (EMS) were recently developed to overcome tumour ingrowth in conventional EMS. However, supporting evidence for the efficacy of covered EMS is ...

Less severe complications included stent migration (5%), pain (2%), biliary obstruction (1%) and stent obstruction (17%). Survival data were available for 458 patients, among whom the mean ...

The stent chosen should be approximately 4−6 cm longer than the stricture. ... (n = 10) or open (n = 10) side-to-side gastrojejunostomy for palliation of malignant GOO.

Background and objective Stent-assisted coil embolization is a well-established treatment of intracranial wide-necked aneurysms. The Neuroform Atlas Stent System is a new generation microstent ...

Objective The primary objective was to assess the performance of a new generation thin-strut sirolimus-eluting coronary stent with abluminal biodegradable polymer in an all comer population. The ...

Lumen-apposing metal stents (LAMS) have been recently developed to improve treatment outcomes in the endoscopic management of pancreatic fluid collections (PFC), particularly in walled-off necrosis ...

Keywords: anastomotic obstruction, self-expandable metal stents, gastric cancer, gastrojejunostomy, esophagojejunostomy. Citation: Lai H, Wu K, Liu Y, Li D, Peng T, Wan Y and Zhang B (2025) Clinical ...

Hybrid Core–Shell Nanofibrous Scaffolds/Stents Deliver Angiotensin II Receptor Blocker to Treat Diabetic Artery Disease. Chen-Hung Lee * Chen-Hung Lee. Division of Cardiology, Department of Internal ...

Khurshid R. Ghani, MBChB, MS, FRCS, discusses how results from the SOUL trial may shape clinical decision-making regarding stent placement. The SOUL trial (NCT05866081) is an ongoing study to assess ...

By 2021, most stent procurement volume tilt toward underdeveloped regions. The procurement volume of selected stents increased by 120.5% in 2021 compared with 2019, comprising 95.5% of the annual ...